Comparison of Cervical-lymph-node-first Presentation of Kawasaki Disease and Typical Kawasaki Disease |
Yun, Hye-Won
(Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Lee, Jun-Yeol (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) Yang, Song-I (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) Yu, Hee-Joon (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) Kang, Min-Jae (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) Lee, So-Yeon (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) Lee, Hae-Ran (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) Kim, Kwang-Nam (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) Kim, Sung-Hye (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) |
1 | Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6. |
2 | Bell DM, Morens DM, Holman RC, Hurwitz ES, Hunter MK. Kawasaki syndrome in the United States: 1976 to 1980. Am J Dis Child 1983;137:211-4. DOI |
3 | Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. J Pediatr 1991;118:680-6. DOI |
4 | Mason WH, Takahashi M. Kawasaki syndrome. Clin Infect Dis 1999;28:169-85. DOI |
5 | Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71. DOI |
6 | Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7. DOI |
7 | Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005;47:232-4. DOI |
8 | Youn YS, Yoon HW, Kim SY, Sul JY, Song CJ, Kim JM, et al. Clinical evaluation of tissue biopsy for children with neck mass; a single center study. Korean J Pediatr 2005;48:839-45. |
9 | Anderson MS, Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics 2005;115:e428-33. DOI |
10 | Rowley AH, Gonzalez-Crussi F, Shulman ST. Kawasaki syndrome. Rev Infect Dis 1988;10:1-15. DOI |
11 | Kao HT, Huang YC, Lin TY. Kawasaki disease presenting as cervical lymphadenitis or deep neck infection. Otolaryngol Head Neck Surg 2001;124:468-70. DOI |
12 | Stamos JK, Corydon K, Donaldson J, Shulman ST. Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics 1994;93:525-8. |
13 | Kim JY, Kim JH, Moon SJ, Cho BS, Cha SH. Clinical characteristics of lymphadenopathy as the initial manifestation of Kawasaki disease. Korean J Pediatr Infect Dis 2000;7:152-8. DOI |
14 | Tashiro N, Matsubara T, Uchida M, Katayama K, Ichiyama T, Furukawa S. Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease. Pediatrics 2002;109:e77. DOI |
15 | Yanagi S, Nomura Y, Masuda K, Koriyama C, Sameshima K, Eguchi T, et al. Early diagnosis of Kawasaki disease in patients with cervical lymphadenopathy. Pediatr Int 2008;50:179-83. DOI |
16 | Kubota M, Usami I, Yamakawa M, Tomita Y, Haruta T. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations. J Paediatr Child Health 2008;44:359-62. DOI |
17 | Kook DH, Ko YM, Lee KY, Kim DU, Lee KY, Lee JS. Characteristics of Kawasaki disease patients who are unresponsive to high-dose intravenous immunoglobulin therapy. Korean J Pediatr Infect Dis 2008;15:180-7. DOI |
18 | Harada K. Intravenous -globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10. DOI |
19 | Zhang T, Yanagawa H, Oki I, Nakamura Y, Yashiro M, Ojima T, et al. Factors related to cardiac sequelae of Kawasaki disease. Eur J Pediatr 1999;158:694-7. DOI |
20 | Nomura Y, Masuda K, Yoshinaga M, Sameshima K, Miyata K. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm. Pediatr Int 2002;44:353-7. DOI |
21 | Muta H, Ishii M, Sakaue T, Egami K, Furui J, Sugahara Y, et al. Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease. Pediatrics 2004;114:751-4. DOI |
22 | Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med 1995;162:322-7. |
23 | Fan P, Chiu C, Yen M, Huang Y, Li C, Lin T. School-aged children with Kawasaki disease: high incidence of cervical lymphadenopathy and coronary artery involvement. J Paediatr Child Health 2003;39:55-7. DOI |
24 | Lee KY, Hong JH, Han JW, Lee JS, Lee BC, Burgner D. Features of Kawasaki disease at the extremes of age. J Paediatr Child Health 2006;42:423-7. DOI |
25 | April MM, Burns JC, Newburger JW, Healy GB. Kawasaki disease and cervical adenopathy. Arch Otolaryngol Head Neck Surg 1989;115:512-4. DOI |
26 | Nomura Y, Arata M, Koriyama C, Masuda K, Morita Y, Hazeki D, et al. A severe form of Kawasaki disease presenting with only fever and cervical lymphadenopathy at admission. J Pediatr 2010;156:786-91. DOI |